OR WAIT 15 SECS
March 24, 2017
Life Sciences Ontario (LSO) has announced a new Chair of its Board of Directors, along with two new Board members.
Effective immediately, Mark Smithyes will assume the role of Chair; he replaces outgoing Chair Paul Lucas, who is now entering retirement. Smithyes has served on LSO’s Board since 2011 and has a career in the pharma and medical device industries spanning 20 years.
LSO also announced the addition of two new Members to its Board: Susan Marlin, President of Clinical Trials Ontario, and Deborah Brown, a management consultant in the pharmaceutical and biotech industry.